Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | IDE | P14735 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HLCS | P50747 | 6/20 | 0.52 |
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | PTPRF | P10586 | 2/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625200 | 0.87 | TDP1 (0.57) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL23124403 | 0.87 | TDP1 (0.57) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL7996104 | 0.83 | TDP1 (0.50) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL29531755 | 0.82 | TDP1 (0.69) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL487045 | 0.81 | TDP1 (0.68) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL425273 | 0.80 | TDP1 (0.67) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL8988137 | 0.80 | TDP1 (0.54) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL4153459 | 0.79 | TDP1 (0.48) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL1936659 | 0.79 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL6036962 | 0.79 | TDP1 (0.65) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180080061-A1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-03-22 | — | — | US | disclosed |
| WO-2016154040-A2 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-09-29 | — | — | WO | disclosed |
| EP-1755667-B1 | STABLE PEPTIDE MIMETIC OF HIV GP41 FUSION INTERMEDIATE | MERCK SHARP & DOHME (US) | 2013-07-17 | — | — | EP | disclosed |
| WO-2013087789-A1 | ANTIBODY ISOFORM ARRAYS AND METHODS THEREOF | GLYKOS FINLAND LTD. (FI) | 2013-06-20 | — | — | WO | disclosed |
| EP-2354153-A2 | Stable peptide mimetic of HIV gp41 fusion intermediate | Merck Sharp & Dohme Corp. (US) | 2011-08-10 | — | — | EP | disclosed |
| US-7811577-B2 | Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity | MERCK SHARP & DOHME CORP. (US) | 2010-10-12 | — | — | US | disclosed |
| EP-1625234-B1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | UNIV LELAND STANFORD JUNIOR (US) | 2009-08-19 | — | — | EP | disclosed |
| WO-2009092808-A1 | METHOD FOR DETECTING PHOSPHOPANTETHEINYL TRANSFERASE ACTIVITY | NATIONAL UNIVERSITY OF IRELAND, MAYNOOTH (IE) | 2009-07-30 | — | — | WO | disclosed |
| EP-1755667-A4 | STABLE PEPTIDE MIMETIC OF HIV GP41 FUSION INTERMEDIATE | MERCK & CO INC (US) | 2008-09-03 | — | — | EP | disclosed |
| US-20070224212-A1 | Stable Peptide Mimetic of Hiv Gp41 Fusion Intermediate | MERCK SHARP & DOHME LLC | 2007-09-27 | — | — | US | disclosed |
| EP-1625234-A4 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | UNIV LELAND STANFORD JUNIOR (US) | 2007-08-22 | — | — | EP | disclosed |
| EP-1755667-A2 | STABLE PEPTIDE MIMETIC OF HIV GP41 FUSION INTERMEDIATE | Merck & Co., Inc. (US) | 2007-02-28 | — | — | EP | disclosed |
| US-20060222869-A1 | Electropen lithography | ENERGY, UNITED STATES DEPARTMENT | 2006-10-05 | — | — | US | disclosed |
| EP-1625234-A1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | The Board of Trustees of The Leland Stanford Junior University (US) | 2006-02-15 | — | — | EP | disclosed |
| WO-2005118886-A2 | STABLE PEPTIDE MIMETIC OF HIV GP41 FUSION INTERMEDIATE | MERCK & CO., INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20040259135-A1 | Biosynthetic labeling and separation of RNA | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-12-23 | — | — | US | disclosed |
| WO-2004101825-A1 | BIOSYNTHETIC LABELING AND SEPARATION OF RNA | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040219542-A1 | Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules | ARIZEKE PHARMACEUTICALS, INC. | 2004-11-04 | — | — | US | disclosed |
| WO-2002074787-A2 | COMPOSITIONS AND METHODS FOR IDENTIFYING, CHARACTERIZING, OPTIMIZING AND USING LIGANDS TO TRANSCYTOTIC MOLECULES | ARIZEKE PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | disclosed |